{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-000521","form_type":"8-K","ticker":"EXPO","cik":"0000851520","company_name":"EXPONENT INC","filed_at":"2024-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.056459+00:00","generated_at":"2026-06-06T12:21:10.181498+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Exponent Q4 net income down to $0.41 EPS; raises dividend to $0.28, adds $61.6M buyback","bullets":["Q4 revenues before reimbursements $113.9M (+1.1% YoY); net income $20.9M ($0.41 diluted EPS) vs $22.5M ($0.44) prior year.","FY2023 net revenues $497.2M (+7.2%); net income $100.3M ($1.94 diluted EPS) vs $102.3M ($1.96).","Guidance: FY2024 revenues before reimbursements flat to down low-single digits; EBITDA margin 25.75%-26.5%.","Quarterly dividend raised to $0.28 from $0.26, payable March 22, 2024; record March 8, 2024.","Board authorized additional $61.6M for share repurchases, total authorization $100M."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-000521","json":"https://secwatch.observer/filing/0001171843-24-000521.json","markdown":"https://secwatch.observer/filing/0001171843-24-000521.md","text":"https://secwatch.observer/filing/0001171843-24-000521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/0001171843-24-000521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/f8k_020124.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T12:21:10.181498+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b87cf630afdd5caef55d0ce2832c18e230c9861","claim":"EXPONENT INC reported fiscal year 2023 ended December 29, 2023 results: revenue $536.8 million, net income $100.3 million, EPS $1.94 per diluted share.","evidence_excerpt":"Total revenues increased 4.6% to $536.8 million for fiscal year 2023, as compared to $513.3 million in fiscal year 2022. Revenues before reimbursements increased 7.2% to $497.2 million, as compared to $463.8 million in fiscal year 2022. Net income was $100.3 million, or $1.94 per diluted share, during fiscal year 2023, as compared to $102.3 million, or $1.96 per diluted share, in fiscal year 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/0001171843-24-000521-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2023 ended December 29, 2023"},{"label":"Revenue","value":"$536.8 million"},{"label":"Net income","value":"$100.3 million"},{"label":"EPS","value":"$1.94 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"8305597342ecc39e2b14590a6b18cfedfa2a72a0","claim":"EXPONENT INC updated its fiscal year 2024 guidance (lowered).","evidence_excerpt":"For fiscal year 2024 as compared to fiscal year 2023, Exponent anticipates: Revenues before reimbursements to be flat to down in the low-single digits; and, EBITDA 1 to be 25.75% to 26.5% of revenues before reimbursements.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/0001171843-24-000521-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2024"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"dea65b6f2701fd858f7afde03ab944334bbf55aa","claim":"EXPONENT INC reported fourth quarter ended December 29, 2023 results: revenue $122.9 million, net income $20.9 million, EPS $0.41 per diluted share.","evidence_excerpt":"Total revenues decreased 3.5% to $122.9 million in the fourth quarter of 2023, as compared to $127.4 million in the fourth quarter of 2022. Revenues before reimbursements increased 1.1% to $113.9 million, as compared to $112.6 million in the fourth quarter of 2022. Net income decreased to $20.9 million, or $0.41 per diluted share, in the fourth quarter of 2023, as compared to $22.5 million, or $0.44 per diluted share, in the same period of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/0001171843-24-000521-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 29, 2023"},{"label":"Revenue","value":"$122.9 million"},{"label":"Net income","value":"$20.9 million"},{"label":"EPS","value":"$0.41 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}